James T. Forbes - Concepedia

Author

James T. Forbes

Vanderbilt University

Also Known As

J Forbes, J T Forbes, J. Forbes, J. Todd Forbes, J.T. Forbes, James T Forbes, James T. Forbes, JamesT. Forbes

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

Vanderbilt University Bureau of Land Management Oregon Department of Fish and Wildlife Oregon State University University of Montana

About

James T. Forbes is an author at Vanderbilt University specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	1.3K
2	Engineering	2	2	54
3	Health Sciences	1	1	72
4	Natural Sciences	1	1	65
5	Allergy	1	1	42

James T. Forbes

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. C. Focan, S. M. Steinberg, M Blichert-Toft, PubMed	1998	2.2K
Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells. Hirokazu Kurokawa, Anne E.G. Lenferink, Jean F. Simpson, PubMed Tumor BiologyBreast OncologyEndocrine-related CancerTamoxifen ResistanceMitogen-activated Protein Kinases	2000	367
Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression. Carlos L. Arteaga, Stephen D. Hurd, Angela R. Winnier, Journal of Clinical Investigation Spleen Natural KillerBreast OncologyImmunologyPathologyImmunologic Mechanism	1993	357
Conditional Overexpression of Active Transforming Growth Factor β1 <b> <i>In vivo</i> </b> Accelerates Metastases of Transgenic Mammary Tumors Rebecca S. Muraoka-Cook, Hirokazu Kurokawa, Yasuhiro Koh, Cancer Research	2004	159
Early Changes in Protein Expression Detected by Mass Spectrometry Predict Tumor Response to Molecular Therapeutics Michelle L. Reyzer, Robert L. Caldwell, Teresa C. Dugger, Cancer Research	2004	149
Inhibition of Mammalian Target of Rapamycin Is Required for Optimal Antitumor Effect of HER2 Inhibitors against HER2-Overexpressing Cancer Cells Todd W. Miller, James T. Forbes, Chirayu Shah, Clinical Cancer Research	2009	131
Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung. David H. Johnson, P. J. Marangos, James T. Forbes, PubMed Tumor BiologyPrognostic BiomarkersBiomarker (Medicine)Potential UtilityMedicine	1984	131
Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-α bigenic mice Anne E.G. Lenferink, Jean F. Simpson, Laura K. Shawver, Proceedings of the National Academy of Sciences	2000	128
Growth inhibition by retinol of a human breast carcinoma cell line in vitro and in athymic mice. Lesa D. Fraker, Susan A. Halter, James T. Forbes PubMed Chemoprevention StrategyCell ProliferationCell GrowthNatural Killer CellsTumor Biology	1984	72
Mannose 6-, fructose 1-, and fructose 6-phosphates inhibit human natural cell-mediated cytotoxicity. James T. Forbes, Roger K. Bretthauer, Thomas N. Oeltmann Proceedings of the National Academy of Sciences ImmunotoxicologyBiochemistryHexose Phosphate ResidueMedicineNatural Sciences	1981	65

Page 1